More on INCY
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $116.93 |
|
|||
| Open | $116.75 | ||||
| 52 Wk High | $118.49 | ||||
| 52 Wk Low | $55.00 | ||||
| Day High | $116.87 | ||||
| Day Low | $115.12 | ||||
| P/E | N/A | ||||
| EPS | $-0.56 | ||||
| Volume | 1,476,823 | ||||
- Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
- Incyte (INCY) PT Raised to $140 at TD Cowen
- Morgan Stanley Assumes Incyte (INCY) at Equalweight
- Form 4 INCYTE CORP For: Oct 15 Filed by: CAGNONI PABLO J
- Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
- Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
- Incyte (INCY) PT Raised to $115 at Truist Securities
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
- Incyte to Report Third Quarter Financial Results
Entities mentioned with incy
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
